RxDoctor Payments Data

Jimmy Dinh, PA

Physician Assistant · Stanford, CANPI 1689216475

Payments from drug & device makers

$3,584in general payments, 2019–2025

Across 42 payments — averaging $85.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Axonics, Inc.$1K
  • AbbVie$125
  • Exact Sciences$125
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$95
  • Dentsply IH AB$37

What the payments were for

  • Travel & lodging$2,13259%
  • Food & beverage$1,41640%
  • Education$361%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,584 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$41,683
Medicare patients
211
Services billed
469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron66$68,003
LinzessLinaclotide61$54,928
MyrbetriqMirabegron39$34,719
MotegrityPrucalopride Succinate37$31,537
XifaxanRifaximin13$26,764
TrulancePlecanatide16$9,587
Estradiol49$3,614
Lubiprostone21$2,163
Methenamine Hippurate11$1,627
Pantoprazole Sodium13$264
Tamsulosin Hcl14$205
Ondansetron Hcl17$172
Gabapentin11$169

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$125$54,92861 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$95$36,35129 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →